Re: AGWG: Please review proposal to close Silver issues

+1


--

Len Beasley

918 630 5419
Colorado (MT)



From: Chuck Adams <charles.adams@oracle.com>
Date: Tuesday, September 9, 2025 at 12:52 PM
To: WCAG <w3c-wai-gl@w3.org>
Subject: [EXTERNAL] AGWG: Please review proposal to close Silver issues

**** External Email - Use Caution ****

________________________________

Members of the Accessibility Guidelines Working Group,



We are asking you to review and approve the closure of the following list of silver issues, which can be found by using the following link:  Silver Issues Ready To Close<https://urldefense.com/v3/__https:/github.com/w3c/silver/issues?q=is*3Aissue*20state*3Aopen*20label*3A*22survey*20*3A*20ready*20for*22__;JSUlJSUlJSUlJSU!!EDx7F7x-0XSOB8YS_BQ!ZmTOhK30xT1_qOSRwBzxsFs1JVXsw75EFzHmApEYoJnOfnRhJEUPpU3FLG3qCFiJs-UFt_cknRNKLotc9onpJA$>.  These are silver issues that I have reviewed since the prior time I have asked for your approval.



These issues are four or more years old, and can be closed because either the issue has been addressed in the current WCAG 3 draft or the issue has become irrelevant due to changes of content in the WCAG 3 draft.



Every issue contains a proposed response explaining the reason for closing the issue.  This explanation includes instructions on opening an issue in WCAG 3 should anybody decide that a closed issue has not been satisfactorily resolved.



We ask that you reply to this email with +1 in support of closing all these issues, or that you identify the issues that you feel should remain open.  Any issues you feel should remain open will be transferred from the Silver repository to the WCAG 3 repository for additional review.

Regards,
Charles Adams

 NOTICE TO RECIPIENT OF INFORMATION:
This e-mail may contain confidential or privileged information. If you think you have received this e-mail in error, please advise the sender by reply e-mail and then delete this e-mail immediately.  

This e-mail may also contain protected health information (PHI) with information about sensitive medical conditions, including, but not limited to, treatment for substance use disorders, behavioral health, HIV/AIDS, or pregnancy. This type of information may be protected by various federal and/or state laws which prohibit any further disclosure without the express written consent of the person to whom it pertains or as otherwise permitted by law. Any unauthorized further disclosure may be considered a violation of federal and/or state law. A general authorization for the release of medical or other information may NOT be sufficient consent for release of this type of information.

Thank you. Aetna